Stock listing

NASDAQ:SNGX Soligenix, Inc. Stock

Home listing (NASDAQ) of Soligenix, Inc.

Follow Soligenix, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:SNGX

$0.22 USD -0.03 (-12.9%)

Close on Nov 20, 2026

Past year -82.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.212 – $0.24 USDNov 20, 2026
Volume
330,314 sharesNov 20, 2026
Market cap
$5.14M USDAt the close on Nov 20, 2026 · price × 23.37M shares outstanding
52-week range
$0.212 – $1.70 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$74,304 USDMedian day 131,600 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Soligenix, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SNGX · Home$0.22 USD-0.033 (-12.9%)330,314$0.24$0.24$0.212$0.253Close on Nov 20, 2026
LSE:0A6I$0.225 USD-0.023 (-9.4%)21,133$0.235$0.238$0.214$0.248Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SNGX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.22-0.033-12.9%$0.24$0.24$0.212330,314
$0.253-0.028-9.9%$0.28$0.281$0.231544,838
$0.281-0.008-2.7%$0.288$0.295$0.276258,161
$0.288-0.033-10.2%$0.315$0.315$0.269693,619
$0.321+0.001+0.3%$0.317$0.323$0.312135,555
$0.32-0.001-0.4%$0.314$0.34$0.31203,049
$0.321+0.001+0.4%$0.32$0.325$0.31662,120
$0.32-0.022-6.3%$0.332$0.35$0.314298,954
$0.342+0.007+2.0%$0.35$0.355$0.34130,787
$0.335+0.002+0.5%$0.33$0.348$0.33106,852
$0.333-0.018-5.0%$0.351$0.355$0.333138,383
$0.351-0.005-1.5%$0.362$0.364$0.35176,181
$0.356-0.005-1.4%$0.36$0.365$0.356114,736
$0.361+0.005+1.5%$0.368$0.37$0.355137,408
$0.356-0.013-3.6%$0.378$0.378$0.35569,423
$0.369-0.006-1.5%$0.376$0.378$0.36836,555
$0.375+0.012+3.3%$0.351$0.375$0.35162,279
$0.363+0.013+3.7%$0.35$0.37$0.3574,407
$0.35-0.02-5.4%$0.369$0.371$0.3547,606
$0.37+0.01+2.8%$0.35$0.37$0.34127,000
$0.36+0.01+2.9%$0.37$0.37$0.35131,600
$0.350.000.0%$0.34$0.37$0.3469,100
$0.35+0.01+2.9%$0.34$0.36$0.3481,200
$0.34-0.01-2.9%$0.34$0.35$0.3469,700
$0.35-0.01-2.8%$0.36$0.36$0.35217,700
$0.36+0.02+5.9%$0.34$0.36$0.34163,200
$0.34+0.01+3.0%$0.32$0.35$0.32148,200
$0.33-0.02-5.7%$0.35$0.37$0.33267,400
$0.35-0.01-2.8%$0.36$0.37$0.3561,800
$0.36+0.01+2.9%$0.35$0.37$0.35114,500
$0.350.000.0%$0.36$0.36$0.35120,200
$0.35-0.01-2.8%$0.36$0.36$0.3562,800
$0.360.000.0%$0.36$0.36$0.36185,600
$0.36-0.01-2.7%$0.36$0.37$0.36107,900
$0.37+0.01+2.8%$0.37$0.37$0.36146,500
$0.360.000.0%$0.36$0.37$0.3645,300
$0.36-0.01-2.7%$0.37$0.37$0.3690,300
$0.37-0.01-2.6%$0.38$0.38$0.36406,600
$0.380.000.0%$0.38$0.38$0.38135,000
$0.38-0.01-2.6%$0.39$0.39$0.3872,700
$0.390.000.0%$0.38$0.39$0.38228,600
$0.390.000.0%$0.39$0.39$0.38372,700
$0.39+0.02+5.4%$0.39$0.39$0.38529,800
$0.370.000.0%$0.38$0.38$0.37341,300
$0.37-0.01-2.6%$0.37$0.39$0.37257,400
$0.38+0.02+5.6%$0.36$0.40$0.36971,500
$0.360.000.0%$0.36$0.36$0.36125,800
$0.360.000.0%$0.36$0.37$0.36288,300
$0.360.000.0%$0.37$0.37$0.3698,400
$0.360.000.0%$0.36$0.37$0.36147,200
$0.36-0.01-2.7%$0.36$0.37$0.36124,100
$0.37-0.01-2.6%$0.38$0.39$0.37126,400
$0.380.000.0%$0.38$0.39$0.3895,200
$0.380.000.0%$0.38$0.38$0.38119,100
$0.380.000.0%$0.39$0.39$0.3859,900
$0.380.000.0%$0.38$0.39$0.3790,000
$0.380.000.0%$0.37$0.39$0.37122,200
$0.380.000.0%$0.38$0.39$0.36400,300
$0.380.000.0%$0.38$0.39$0.37139,500
$0.380.000.0%$0.38$0.39$0.38379,200
$0.38-0.03-7.3%$0.40$0.40$0.38590,900
$0.41+0.01+2.5%$0.41$0.41$0.40218,100
$0.400.000.0%$0.41$0.41$0.40311,100
$0.40+0.02+5.3%$0.38$0.42$0.38989,200
$0.380.000.0%$0.38$0.39$0.3894,000

Splits

5 splits since 1997 · NASDAQ:SNGX · every price before a split is adjusted for it

DayRatioWhat
1-for-16Consolidation
1-for-15Consolidation
1-for-10Consolidation
1-for-20Consolidation
1-for-15Consolidation
Ticker
NASDAQ:SNGX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Soligenix, Inc. news

Soligenix, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 192 in all · newest Nov 6, 2026 · oldest 2019
Decks
49 decks · latest Apr 8, 2026

Where Soligenix, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SNGX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:SNGXBOATSUnited StatesUSD
gettex:DOA0gettexGermanyEUR
LSE:0A6ILSEUnited KingdomUSD
Munich:DOA0MunichGermanyEUR

Valuation

Price/book 0.8× against a median of 1.2×: 2nd lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$3.61M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.8×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.76

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Soligenix, Inc. · NASDAQ:SNGXUS$5.14M−US$3.61Mn/an/an/a0.8×n/a0.0×1.76
Hemostemix Inc · TSXV:HEMUS$5.35MUS$7.70Mn/an/an/an/an/an/a0.47
Curative Biotechnology Inc · OTC:CUBTUS$5.34MUS$6.55Mn/an/an/an/an/an/a1.27
Abpro Holdings, Inc. · OTC:ABPOUS$5.31MUS$1.07M2.6×n/an/an/an/an/a-0.79
CNS Pharmaceuticals, Inc. · NASDAQ:CNSPUS$5.25M−US$11.96Mn/an/an/a0.3×n/a0.0×0.74
Rakovina Therapeutics Inc · TSXV:RKVUS$5.10MUS$7.20Mn/an/an/an/an/an/a-0.43
StimCell Energetics Inc. · OTC:STMEUS$5.10MUS$5.09Mn/an/an/an/an/an/a0.99
Longeveron Inc. · NASDAQ:LGVNUS$5.05M−US$1.78Mn/a−1.5×n/a1.1×n/a0.1×1.55
Oncodesign Precision Medicine S.A. · EURONEXT:ALOPMUS$5.04MUS$8.61M0.8×30.0×0.9×1.2×n/a1.6×n/a
Patrys Limited · ASX:PABUS$4.96MUS$4.47Mn/a8.2×n/a10.2×−363.7%0.0×n/a
Invex Therapeutics Ltd. · ASX:IXCUS$4.86MUS$2.20Mn/an/an/a1.9×n/a0.0×n/a
Median of the othersUS$5.10MUS$4.78M1.7×8.2×0.9×1.2×−363.7%0.0×0.74

Forecasts

1 strong buy · Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.

Price target
1.38 USD · Analysts' mean
EPS, year to Dec 2026
-0.40 · 1 analyst

Team and board

Officers

OfficerRole
Christopher J. SchaberChairman, President and Chief Executive Officer
Jonathan L. GuarinoSenior Vice President and Chief Financial Officer
Adam T. RumageSenior Vice President, Project Management & Regulatory Affairs
Oreola DoniniSenior Vice President and Chief Scientific Officer

Board

DirectorRole
Christopher J. SchaberChairman, President and Chief Executive Officer
Diane L. ParksBoard Director
Gregg A. LapointeBoard Director
Jerome ZeldisBoard Director
Robert J. RubinBoard Director

Events

QuarterResultsShare move
Q3 2026Nov 6, 2026 · After close+2.0%
Q2 2026Aug 7, 20260.0%
Q1 2026May 8, 2026 · After close−3.5%
Q3 2025Nov 7, 2025 · After close−0.7%
Q2 2025Aug 14, 2025 · After close−5.4%
Q1 2025May 9, 2025 · After close−1.0%
Q4 2024Mar 13, 2025 · Before open−0.9%
Q3 2024Nov 8, 2024 · After close+2.6%
Q2 2024Aug 9, 2024 · After close−1.6%
Q1 2024May 10, 2024 · After close−2.5%
All 20 quarters
QuarterResultsShare move
Q4 2023Mar 15, 2024 · After close−1.6%
Q3 2023Nov 13, 2023 · After close−2.4%
Q2 2023Aug 21, 2023 · Before open+2.2%
Q1 2023May 15, 2023 · Before open+6.4%
Q4 2022Mar 31, 2023 · Before open−3.9%
Q3 2022Nov 10, 2022 · After close+4.5%
Q2 2022Aug 12, 2022 · After close−2.3%
Q1 2022May 13, 2022 · After close+5.0%
Q4 2021Mar 29, 2022 · Before open+1.4%
Quarter to Sep 30, 2021Nov 12, 2021 · After close0.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (April 2026)Investor deck26 slidesApr 8, 2026
Investor Presentation (January 2026)Investor deck26 slidesJan 8, 2026
Investor Presentation (November 2025)Investor deck26 slidesNov 24, 2025
Investor Presentation (September 2025)Investor deck26 slidesSep 19, 2025
Investor Presentation (August 2025)Investor deck26 slidesAug 22, 2025
Investor Presentation (May 2025)Investor deck24 slidesMay 1, 2025
Investor Presentation (March 2025)Investor deck24 slidesMar 6, 2025
Investor Presentation (January 2025)Investor deck24 slidesJan 14, 2025
Investor Presentation (October 2024)Investor deck24 slidesOct 3, 2024
Investor Presentation (June 2024)Investor deck24 slidesJun 10, 2024
All 49 decks
DeckKindSlidesDate
Investor Presentation (April 2024)Investor deck24 slidesApr 11, 2024
Investor Presentation (December 2023)Investor deck23 slidesDec 6, 2023
Investor Presentation (October 2023)Investor deck23 slidesOct 3, 2023
Investor Presentation (July 2023)Investor deck23 slidesJul 15, 2023
Investor Presentation (June 2023)Investor deck23 slidesJun 22, 2023
Investor Presentation (December 2022)Investor deck25 slidesDec 19, 2022
Investor Presentation (November 2022)Investor deck25 slidesNov 3, 2022
Investor Presentation (August 2022)Investor deck25 slidesAug 12, 2022
Investor Presentation (May 2022)Investor deck25 slidesMay 16, 2022
Investor Presentation (January 2022)Investor deck24 slidesJan 3, 2022
Investor Presentation (September 2021)Investor deck24 slidesSep 25, 2021
Investor Presentation (May 2021)Investor deck24 slidesMay 2021
Investor Presentation (January 2021)Investor deck71 slidesJan 26, 2021
Investor Presentation (September 2020)Investor deck36 slidesSep 10, 2020
Investor Presentation (June 2019)Investor deck23 slidesJun 12, 2019
Investor Presentation (July 2018)Investor deck21 slidesJuly 2018
Investor Presentation (January 2018)Investor deck25 slidesJan 25, 2018
Investor Presentation (September 2017)Investor deck25 slidesSep 29, 2017
Investor Presentation (June 2017)Investor deck26 slidesJun 14, 2017
Investor Presentation (March 2017)Investor deck26 slidesMarch 2017
Investor Presentation (February 2017)Investor deck25 slidesFeb 23, 2017
Investor Presentation (January 2017)Investor deck25 slidesJanuary 2017
Technical Presentation (December 2016)Technical61 slidesDec 16, 2016
Investor Presentation (October 2016)Investor deck17 slidesOctober 2016
Technical Presentation (August 2016)Technical36 slidesAugust 2016
Investor Presentation (June 2016)Investor deck25 slidesJun 22, 2016
Investor Presentation (May 2016)Investor deck25 slidesMay 2016
Investor Presentation (January 2016)Investor deck25 slidesJan 7, 2016
Investor Presentation (August 2015)Investor deck29 slidesAug 31, 2015
Investor Presentation (June 2015)Investor deck29 slidesJun 3, 2015
Investor Presentation (January 2015)Investor deck30 slidesJan 7, 2015
Investor Presentation (September 2014)Investor deck30 slidesSep 8, 2014
Moderated Conference Call: Oral Mucositis - Advancing the Next Generation of Therapies (November 2013)Conference22 slidesNov 5, 2013
Investor Presentation (September 2013)Investor deck25 slidesSep 27, 2013
Investor Presentation (July 2013)Investor deck26 slidesJul 12, 2013
Investor Presentation (July 2013)Investor deck26 slidesJuly 2013
Investor Presentation (January 2013)Investor deck25 slidesJan 10, 2013
Investor Presentation (June 2012)Investor deck25 slidesJun 27, 2012
Investor Presentation (April 2012)Investor deck25 slidesApr 5, 2012

Open Decks

Financings

RaiseDate
Public offering of shares of common stock (or common stock equivalents) and warrants
Closed: US$7.5M raised · US$1.35 a share · Warrants at US$1.35 for 60 months · A.G.P./Alliance Global Partners
Dealers: A.G.P./Alliance Global Partners (lead)
Use of proceeds: Research and development and commercialization activities, working capital and general corporate purposes
Sep 29, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0119.4K839.4K948.9K824.3K2.36M4.63M5.24M5.43M10.4M
Cost of revenue0119.4K742.0K550.8K728.6K1.82M3.57M4.60M4.31M8.43M
Gross profit0-119.4K97.3K398.1K95.6K538.5K1.06M643.7K1.12M2.02M
Research and development7.49M5.22M3.31M7.94M8.19M9.80M8.12M6.75M5.51M4.30M
Selling, general and administrative4.36M4.22M4.48M6.69M5.01M4.33M3.48M2.95M3.21M3.43M
Operating income-11.8M-9.44M-7.70M-14.2M-13.1M-18.6M-10.5M-9.06M-7.59M-5.71M
Depreciation and amortization3.22K5.81K6.55K24.6K34.2K62.4K54.5K44.1K68.6K89.9K
EBITDA-11.8M-9.43M-7.69M-14.2M-13.1M-18.5M-10.5M-9.01M-7.53M-5.62M
Interest expense214.0K49.1K822.6K904.5K34.3K133.3K000
Income before tax-11.6M-8.68M-7.91M-15.0M-13.4M-18.5M-9.97M-8.90M-7.56M-3.78M
Income tax-506.6K-409.1K-1.77M-1.15M-864.7K-836.9K-610.7K159.0K-416.8K-530.1K
Net income-11.1M-8.27M-6.14M-13.8M-12.6M-17.7M-9.36M-8.90M-7.15M-3.25M
Earnings per share, basic-2.14-4.98-12.66-4.81-4.69-0.64-0.48-0.68-1.16-0.93
Earnings per share, diluted-2.14-4.98-12.66-4.81-4.69-0.64-0.48-0.68-1.16-1.34

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents7.94M7.82M8.45M13.4M26.0M18.7M5.42M8.98M7.81M8.77M
Short-term investments00
Receivables195.1K219.3K242.7K564.9K1.46M1.20M1.34M1.21M
Inventory112111
Current assets8.85M8.83M9.51M13.9M26.6M19.5M7.49M10.3M9.42M10.1M
Property, plant and equipment8.77K6.11K11.9K18.5K22.2K23.5K36.1K19.6K37.2K26.7K
Goodwill00
Total assets9.24M8.97M9.80M14.3M26.9M19.9M7.78M10.5M9.55M10.3M
Accounts payable1.12M667.9K1.11M3.87M2.93M2.13M2.74M2.13M1.75M1.71M
Current liabilities3.70M4.85M6.15M16.5M6.29M6.08M6.31M4.21M3.23M2.87M
Long-term debt1.01M9.86M9.95M6.15K00
Total debt358.1K01.01M09.96M10.5M127.2K
Total liabilities3.94M4.85M7.27M16.8M16.1M16.1M6.32M4.21M3.23M2.87M
Shareholders' equity5.29M4.12M2.52M-2.47M10.7M3.74M1.46M6.28M6.32M7.40M
Shares outstanding10.1M2.51M648.8K2.91M2.86M30.6M21.8M17.7M8.73M5.47M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-10.3M-8.40M-8.60M-12.6M-11.7M-11.5M-7.51M-7.24M-6.51M-4.98M
Capital spending-5.88K0-1-13.1K-11.8K-7.15K-30.2K-1.93K-26.3K-7.16K
Free cash flow-10.3M-8.40M-8.60M-12.7M-11.8M-11.5M-7.54M-7.25M-6.54M-4.99M
Cash from investing-5.88K-13.1K-11.8K-7.15K-24.7K-925-26.3K-7.16K
Cash from financing10.4M7.76M3.66M76.8K19.1M24.7M4.01M8.42M5.57M8.84M
Dividends paid-4300
Share buybacks4.99K4.14M8.68M6.25M-809.3K
Change in cash116.6K-626.6K-4.91M-12.7M7.37M13.3M-3.56M1.17M-963.1K3.85M

Open Financials

Filings

FilingDateTypeFiled with
424B3 · ProspectusNov 6, 2026Offer documentSEC
424B3 · ProspectusNov 6, 2026Offer documentSEC
424B3 · ProspectusNov 6, 2026Offer documentSEC
424B3 · ProspectusNov 6, 2026Offer documentSEC
10-Q · Quarterly reportNov 6, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 2, 2026Big-stake noticeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
8-K · Current reportSep 21, 2026Meeting outcomeSEC
4 · Change in ownershipSep 18, 2026Insider tradeSEC
4 · Change in ownershipSep 18, 2026Insider tradeSEC
4 · Change in ownershipSep 18, 2026Insider tradeSEC
4 · Change in ownershipSep 18, 2026Insider tradeSEC
424B3 · ProspectusAug 7, 2026Offer documentSEC
424B3 · ProspectusAug 7, 2026Offer documentSEC
424B3 · ProspectusAug 7, 2026Offer documentSEC
424B3 · ProspectusAug 7, 2026Offer documentSEC
10-Q · Quarterly reportAug 7, 2026Quarterly reportSEC
ARS · Annual report to shareholdersAug 3, 2026Annual reportSEC
DEFA14A · Additional proxy materialAug 3, 2026Meeting noticeSEC
DEF 14A · Proxy statementAug 3, 2026Meeting noticeSEC
PRER14AJul 23, 2026Other filingsSEC
PRE 14A · Preliminary proxy statementJul 21, 2026Meeting noticeSEC
8-K · Current reportJun 26, 2026Current reportSEC
424B5 · ProspectusJun 26, 2026Offer documentSEC
SCHEDULE 13G · Big-stake noticeJun 25, 2026Big-stake noticeSEC
8-K · Current reportJun 12, 2026Management or board changeSEC
8-K · Current reportMay 28, 2026Current reportSEC
424B5 · ProspectusMay 28, 2026Offer documentSEC
424B3 · ProspectusMay 8, 2026Offer documentSEC
424B3 · ProspectusMay 8, 2026Offer documentSEC
424B3 · ProspectusMay 8, 2026Offer documentSEC
424B3 · ProspectusMay 8, 2026Offer documentSEC
10-Q · Quarterly reportMay 8, 2026Quarterly reportSEC
8-K · Current reportApr 28, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveApr 3, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveApr 3, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveApr 3, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveApr 3, 2026Other filingsSEC
POS AM · Amendment to an effective registrationMar 31, 2026Offer documentSEC
POS AM · Amendment to an effective registrationMar 31, 2026Offer documentSEC
POS AM · Amendment to an effective registrationMar 31, 2026Offer documentSEC
POS AM · Amendment to an effective registrationMar 31, 2026Offer documentSEC
10-K · Annual reportMar 31, 2026Annual reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
8-K · Current reportFeb 12, 2026Current reportSEC
424B5 · ProspectusJan 23, 2026Offer documentSEC
8-K · Current reportJan 23, 2026Current reportSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
8-K · Current reportNov 18, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
424B3 · ProspectusNov 7, 2025Offer documentSEC
424B3 · ProspectusNov 7, 2025Offer documentSEC
424B3 · ProspectusNov 7, 2025Offer documentSEC
10-Q · Quarterly reportNov 7, 2025Quarterly reportSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeOct 1, 2025Big-stake noticeSEC
8-K · Current reportSep 29, 2025Material contractSEC
424B4 · ProspectusSep 26, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 26, 2025Other filingsSEC
CORRESP · Letter to the SECSep 23, 2025Other filingsSEC
CORRESP · Letter to the SECSep 23, 2025Other filingsSEC
S-1 · Registration statementSep 19, 2025Offer documentSEC
UPLOAD · Letter from the SECSep 2, 2025Other filingsSEC
DRS · Draft registration statementAug 27, 2025Offer documentSEC
8-K · Current reportAug 18, 2025Current reportSEC
424B3 · ProspectusAug 15, 2025Offer documentSEC
8-K · Current reportAug 15, 2025Current reportSEC
424B3 · ProspectusAug 15, 2025Offer documentSEC
424B3 · ProspectusAug 15, 2025Offer documentSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportJul 31, 2025Current reportSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
S-8 · Registration statement for employee plansJun 20, 2025Offer documentSEC
8-K · Current reportJun 20, 2025Management or board changeSEC
10-Q · Quarterly reportMay 9, 2025Quarterly reportSEC
ARS · Annual report to shareholdersMay 5, 2025Annual reportSEC
DEFA14A · Additional proxy materialMay 5, 2025Meeting noticeSEC
DEF 14A · Proxy statementMay 5, 2025Meeting noticeSEC
8-K · Current reportMar 28, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveMar 27, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveMar 27, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveMar 27, 2025Other filingsSEC
POS AM · Amendment to an effective registrationMar 21, 2025Offer documentSEC
POS AM · Amendment to an effective registrationMar 21, 2025Offer documentSEC
POS AM · Amendment to an effective registrationMar 21, 2025Offer documentSEC
10-K · Annual reportMar 21, 2025Annual reportSEC
8-K · Current reportFeb 10, 2025Current reportSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
424B3 · ProspectusNov 8, 2024Offer documentSEC
424B3 · ProspectusNov 8, 2024Offer documentSEC
424B3 · ProspectusNov 8, 2024Offer documentSEC
10-Q · Quarterly reportNov 8, 2024Quarterly reportSEC
8-K · Current reportOct 11, 2024Material contractSEC
424B5 · ProspectusAug 16, 2024Offer documentSEC
8-K · Current reportAug 16, 2024Current reportSEC
424B3 · ProspectusAug 9, 2024Offer documentSEC
424B3 · ProspectusAug 9, 2024Offer documentSEC
10-Q · Quarterly reportAug 9, 2024Quarterly reportSEC
EFFECT · Notice that a registration is effectiveAug 5, 2024Other filingsSEC
CORRESP · Letter to the SECJul 30, 2024Other filingsSEC
UPLOAD · Letter from the SECJul 29, 2024Other filingsSEC
8-K · Current reportJul 25, 2024Material contractSEC
S-1 · Registration statementJul 24, 2024Offer documentSEC
8-K · Current reportJul 9, 2024Material contractSEC
8-K · Current reportMay 31, 2024Management or board changeSEC
DEFA14A · Additional proxy materialMay 29, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialMay 28, 2024Meeting noticeSEC
8-K · Current reportMay 24, 2024Meeting outcomeSEC
DEFA14A · Additional proxy materialMay 22, 2024Meeting noticeSEC
8-K · Current reportMay 17, 2024Current reportSEC
DEFA14A · Additional proxy materialMay 17, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialMay 15, 2024Meeting noticeSEC
424B3 · ProspectusMay 10, 2024Offer documentSEC
10-Q · Quarterly reportMay 10, 2024Quarterly reportSEC
ARS · Annual report to shareholdersApr 29, 2024Annual reportSEC
DEF 14A · Proxy statementApr 29, 2024Meeting noticeSEC
8-K · Current reportApr 22, 2024Material contractSEC
PRE 14A · Preliminary proxy statementApr 19, 2024Meeting noticeSEC
424B4 · ProspectusApr 19, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveApr 17, 2024Other filingsSEC
CORRESP · Letter to the SECApr 15, 2024Other filingsSEC
CORRESP · Letter to the SECApr 15, 2024Other filingsSEC
CORRESP · Letter to the SECApr 3, 2024Other filingsSEC
8-K · Current reportApr 3, 2024Current reportSEC
CORRESP · Letter to the SECApr 2, 2024Other filingsSEC
CORRESP · Letter to the SECApr 2, 2024Other filingsSEC
S-1/A · Registration statement, amendedApr 2, 2024Offer documentSEC
S-1/A · Registration statement, amendedMar 15, 2024Offer documentSEC
10-K · Annual reportMar 15, 2024Annual reportSEC
UPLOAD · Letter from the SECJan 19, 2024Other filingsSEC
S-1 · Registration statementJan 12, 2024Offer documentSEC
8-K · Current reportDec 22, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveDec 18, 2023Other filingsSEC
4 · Change in ownershipDec 15, 2023Insider tradeSEC
4 · Change in ownershipDec 15, 2023Insider tradeSEC
4 · Change in ownershipDec 15, 2023Insider tradeSEC
4 · Change in ownershipDec 15, 2023Insider tradeSEC
8-K · Current reportDec 15, 2023Meeting outcomeSEC
CORRESP · Letter to the SECDec 14, 2023Other filingsSEC
4 · Change in ownershipDec 8, 2023Insider tradeSEC
4 · Change in ownershipDec 8, 2023Insider tradeSEC
4 · Change in ownershipDec 8, 2023Insider tradeSEC
4 · Change in ownershipDec 8, 2023Insider tradeSEC
S-3/A · Registration statement, amendedDec 8, 2023Offer documentSEC
CORRESP · Letter to the SECDec 6, 2023Other filingsSEC
CORRESP · Letter to the SECNov 30, 2023Other filingsSEC
8-K · Current reportNov 17, 2023Meeting outcomeSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
8-K · Current reportOct 20, 2023Meeting outcomeSEC
DEFA14A · Additional proxy materialOct 17, 2023Meeting noticeSEC
DEFA14A · Additional proxy materialOct 17, 2023Meeting noticeSEC
DEFA14A · Additional proxy materialOct 16, 2023Meeting noticeSEC
DEFA14A · Additional proxy materialOct 13, 2023Meeting noticeSEC
DEFA14A · Additional proxy materialOct 11, 2023Meeting noticeSEC
DEFA14A · Additional proxy materialOct 11, 2023Meeting noticeSEC
DEFA14A · Additional proxy materialSep 22, 2023Meeting noticeSEC
8-K · Current reportSep 22, 2023Meeting outcomeSEC
DEFA14A · Additional proxy materialSep 15, 2023Meeting noticeSEC
8-K · Current reportSep 15, 2023Current reportSEC
UPLOAD · Letter from the SECSep 12, 2023Other filingsSEC
S-3 · Registration statementAug 30, 2023Offer documentSEC
10-Q · Quarterly reportAug 21, 2023Quarterly reportSEC
NT 10-Q · Late filing noticeAug 14, 2023Explanation requestSEC
ARS · Annual report to shareholdersAug 7, 2023Annual reportSEC
DEFA14A · Additional proxy materialAug 7, 2023Meeting noticeSEC
DEF 14A · Proxy statementAug 7, 2023Meeting noticeSEC
8-K · Current reportJul 7, 2023Management or board changeSEC
8-K · Current reportJun 23, 2023Current reportSEC
8-K · Current reportMay 26, 2023Current reportSEC
10-Q · Quarterly reportMay 15, 2023Quarterly reportSEC
8-K · Current reportMay 9, 2023Material contractSEC
EFFECT · Notice that a registration is effectiveMay 8, 2023Other filingsSEC
424B4 · ProspectusMay 5, 2023Offer documentSEC
4 · Change in ownershipMay 5, 2023Insider tradeSEC
3 · Initial statement of ownershipMay 5, 2023Insider tradeSEC
CORRESP · Letter to the SECMay 4, 2023Other filingsSEC
S-1/A · Registration statement, amendedMay 4, 2023Offer documentSEC
8-K · Current reportMay 3, 2023Material contractSEC
8-K · Current reportMay 1, 2023Current reportSEC
S-1/A · Registration statement, amendedApr 19, 2023Offer documentSEC
CORRESP · Letter to the SECApr 19, 2023Other filingsSEC

This page holds 200 of 1,006 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Soligenix, Inc.’s releases · as of Oct 30, 2026

Common shares
23,368,754
Fully diluted
23,368,754

Fully diluted

LineSharesAs of
Common shares23,368,754Oct 30, 2026

Warrants and options

Lot
Warrants · US$1.35 · expire about Sep 2030

Share count over time

CountShares
Oct 30, 202623,368,754

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Citadel628K2.7%US$227KSep 30, 2026
XTX Topco Ltd146K0.63%US$52,879Sep 30, 2026
Vanguard135K0.58%US$48,841Sep 30, 2026
Geode Capital106K0.45%US$38,232Sep 30, 2026
Jane Street62,7090.27%US$22,700Sep 30, 2026
StoneX Group Inc.56,7090.24%US$21,343Sep 30, 2026
Renaissance Technologies44,9000.19%US$16,254Sep 30, 2026
Northern Trust38,0460.16%US$13,773Sep 30, 2026
Virtu Financial LLC19,5960.08%US$7,000Sep 30, 2026
Two Sigma13,0660.06%US$4,730Sep 30, 2026
All 22 holders
HolderSharesOf the companyValueAs of
Citigroup Inc9,9610.04%US$3,606Sep 30, 2026
Morgan Stanley3,5920.02%US$1,300Sep 30, 2026
UBS3,3550.01%US$1,214Sep 30, 2026
Wells Fargo1,550<0.01%US$561Sep 30, 2026
Jones Financial Companies Lllp1,236<0.01%US$475Sep 30, 2026
Plante Moran Financial Advisors, LLC209<0.01%US$76Sep 30, 2026
RBC5<0.01%Sep 30, 2026
SBI Securities Co., Ltd.2<0.01%US$1Sep 30, 2026
Osaic Holdings, Inc.1<0.01%Sep 30, 2026
Caitong International Asset Management Co., Ltd1<0.01%Sep 30, 2026
IFP Advisors, Inc1<0.01%Sep 30, 2026
JPMorgan1<0.01%Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund81,0050.35%US$32,078Jun 30, 2026
Fidelity Extended Market Index Fund76,1760.33%US$69,320May 31, 2026
Fidelity Series Total Market Index Fund14,4590.06%US$13,158May 31, 2026
Fidelity Total Market Index Fund8,0540.03%US$7,329May 31, 2026

Big stakes

StakeStakeSharesDateFiling
MJL Manager LLC9.40%2.05MSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jerome Zeldis
Other companies: NexGel, Inc (Director · Since at least Mar 8, 2021); PTC Therapeutics, Inc. (Director · Since at least Jun 19, 2013); NexImmune, Inc. (Executive VP of Research & Dev · Feb 11, 2021 – Apr 5, 2022 · Past); MetaStat Inc (Director · Oct 11, 2017 – Oct 11, 2017 · Past); Beyond Air, Inc. (Director · Mar 14, 2017 – Mar 14, 2017 · Past); Sorrento Therapeutics, Inc. (See Remarks · Aug 12, 2016 – Nov 26, 2018 · Past); Streamex Corp. (Director · Jul 20, 2015 – Jul 14, 2020 · Past)
Board Director · Since at least Jun 22, 2011
Keith L Brownlie
Other companies: Celldex Therapeutics, Inc. (Director · Since at least Jun 15, 2017); Cancer Genetics Inc (Director · Jul 24, 2013 – May 22, 2014 · Past); Phio Pharmaceuticals Corp. (Director · Mar 1, 2013 – Feb 13, 2019 · Past)
Director · Jun 21, 2012 – Sep 27, 2018 · Past
James S Kuo
Other companies: Theriva Biologics, Inc. (Chairman, CEO & President, Director · Dec 22, 2009 – Aug 30, 2011 · Past)
Director · Jun 4, 2009 – Jun 4, 2009 · Past
Adam T. RumageSenior Vice President, Project Management & Regulatory Affairs · Since at least Nov 5, 2026
Christopher J. SchaberChairman, President and Chief Executive Officer · Since at least Apr 22, 2019
Diane L. ParksBoard Director · Since at least Nov 5, 2026
Gregg A. LapointeBoard Director · Since at least Nov 5, 2026
Jonathan L. GuarinoSenior Vice President and Chief Financial Officer · Since at least Nov 15, 2024
Mark E PearsonDirector · Jul 2, 2018 – Sep 6, 2019 · Past
Oreola DoniniSenior Vice President and Chief Scientific Officer · Since at least Dec 11, 2025
All 12 people
PersonSeat
Robert J. RubinBoard Director · Since at least Jun 16, 2016
Timothy R CoteDirector · May 3, 2023 – May 3, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Soligenix, Inc.